Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older who received care at Xuanwu Hospital, Capital Medical University between March 2026 and May 2026.
- People who have been diagnosed with either ischemic stroke or Alzheimer's disease using standard medical diagnostic methods.
- People who had a lumbar puncture (a procedure to collect fluid from around the spine) performed as part of their normal medical care, not just for research.
- People for whom there is leftover spinal fluid available after all routine medical tests have been completed.
- People who are able to give written consent themselves, or who have a legally appointed representative who can give consent on their behalf.
- For those with ischemic stroke: people who had a baseline neurological assessment recorded and for whom a follow-up assessment is planned at 90 days to measure recovery and functioning.
Who may not be able to join:
- People whose lumbar puncture was done only for research reasons rather than as part of their regular medical care.
- People whose leftover spinal fluid sample is not large enough for the research testing required.
- People whose spinal fluid sample contains a large amount of blood or contamination that would make the research testing unreliable.
- People with a known infection of the brain or spinal cord, cancer affecting the membranes around the brain, or other inflammatory or tumour-related conditions that the study doctor believes would significantly affect the research results.
- People from whom informed consent cannot be obtained, either directly or through a legally appointed representative.
- People with ischemic stroke whose key medical records are incomplete — for example, missing neurological scores recorded on admission or discharge, or for whom the 90-day follow-up assessment is not planned.
- People who the study doctor considers unsuitable for the study for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8617600104266
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Association Between Cerebrospinal Fluid MitoTracker-Positive Event Count and 90-Day Modified Rankin Scale Score in Patients With Ischemic Stroke
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.